Related references
Note: Only part of the references are listed.Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis
Yun Pyo Kang et al.
CELL METABOLISM (2021)
Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer
Fang Huang et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth
Abigail S. Krall et al.
CELL METABOLISM (2021)
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer
Youngtae Jeong et al.
CLINICAL CANCER RESEARCH (2020)
The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin et al.
CANCER DISCOVERY (2020)
Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino Acids
Sarah E. LeBoeuf et al.
CELL METABOLISM (2020)
MYC, MYCL, and MYCN as therapeutic targets in lung cancer
Daniel Masso-Valles et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma
Kewen Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function
Nathan P. Ward et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Mitochondrial ubiquinol oxidation is necessary for tumour growth
Inmaculada Martinez-Reyes et al.
NATURE (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
Connor O'Leary et al.
PHARMACEUTICALS (2020)
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
Rodrigo Romero et al.
NATURE CANCER (2020)
Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis
Qingsong Wang et al.
PLOS ONE (2020)
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
Jiyeon Kim et al.
NATURE METABOLISM (2020)
Autophagy modulates lipid metabolism to maintain metabolic flexibility for Lkb1-deficient Kras-driven lung tumorigenesis
Vrushank Bhatt et al.
GENES & DEVELOPMENT (2019)
Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
Kim Vriens et al.
NATURE (2019)
LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma
Ana Galan-Cobo et al.
CANCER RESEARCH (2019)
Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability
Mark R. Sullivan et al.
ELIFE (2019)
Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
Yun Pyo Kang et al.
ELIFE (2019)
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
K. Hastings et al.
ANNALS OF ONCOLOGY (2019)
Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
Luca Lignitto et al.
CELL (2019)
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Milind D. Chalishazar et al.
CLINICAL CANCER RESEARCH (2019)
An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation
Christopher W. Murray et al.
CANCER DISCOVERY (2019)
The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC
Pablo E. Hollstein et al.
CANCER DISCOVERY (2019)
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
Pei-Hsuan Chen et al.
MOLECULAR CELL (2019)
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Huiying Han et al.
CANCER CELL (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
Milica Momcilovic et al.
NATURE (2019)
Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma
Sarah A. Best et al.
NATURE COMMUNICATIONS (2019)
Assessment of Tumor Redox Status through (S)-4-(3-[18F] fluoropropyl)-L-Glutamic Acid PET Imaging of System xc- Activity
Patrick N. McCormick et al.
CANCER RESEARCH (2019)
Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer Models
Lillian J. Eichner et al.
CELL METABOLISM (2019)
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial
Claudio Vernieri et al.
CLINICAL LUNG CANCER (2019)
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice
Gunnar Boysen et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Shunsuke Kitapma et al.
CANCER DISCOVERY (2019)
Improving the metabolic fidelity of cancer models with a physiological cell culture medium
Johan Vande Voorde et al.
SCIENCE ADVANCES (2019)
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Milica Momcilovic et al.
CANCER CELL (2018)
Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase
Dana M. Gwinn et al.
CANCER CELL (2018)
Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers
Fang Huang et al.
CELL METABOLISM (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer
Yonathan Lissanu Deribe et al.
NATURE MEDICINE (2018)
Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
Michael L. Schulte et al.
NATURE MEDICINE (2018)
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Xiangming Ji et al.
ONCOGENE (2018)
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis et al.
CANCER DISCOVERY (2018)
A selective high affinity MYC-binding compound inhibits MYC: MAX interaction and MYC-dependent tumor cell proliferation
Alina Castell et al.
SCIENTIFIC REPORTS (2018)
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Milica Momcilovic et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Metabolomic profiling of human lung tumor tissues - nucleotide metabolism as a candidate for therapeutic interventions and biomarkers
Paula Moreno et al.
MOLECULAR ONCOLOGY (2018)
Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma
Claudio R. Scafoglio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600E In Vivo
Michael L. Schulte et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
Youngtae Jeong et al.
CANCER DISCOVERY (2017)
Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity
Frances K. Turrell et al.
GENES & DEVELOPMENT (2017)
LKB1 promotes metabolic flexibility in response to energy stress
Seth J. Parker et al.
METABOLIC ENGINEERING (2017)
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Jiyeon Kim et al.
NATURE (2017)
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
Rodrigo Romero et al.
NATURE MEDICINE (2017)
ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways
Thuc M. Le et al.
NATURE COMMUNICATIONS (2017)
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
Justin Goodwin et al.
NATURE COMMUNICATIONS (2017)
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism
Claudia Fumarola et al.
ONCOTARGET (2017)
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
Medhi Wangpaichitr et al.
ONCOTARGET (2017)
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer
Milica Momcilovic et al.
CELL REPORTS (2017)
Phosphorylation of TXNIP by AKT Mediates Acute Influx of Glucose in Response to Insulin
Althea N. Waldhart et al.
CELL REPORTS (2017)
Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
Alexander Muir et al.
ELIFE (2017)
Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake
Muheeb Beg et al.
ELIFE (2017)
Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer
Volkan I. Sayin et al.
ELIFE (2017)
Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer
Liron Bar-Peled et al.
CELL (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
Metabolic Instruction of Immunity
Michael D. Buck et al.
CELL (2017)
Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase
Jason R. Cantor et al.
CELL (2017)
[18F](2S,4R)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition
Rong Zhou et al.
CANCER RESEARCH (2017)
Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer
Mohamed Hassanein et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Molecular features of biguanides required for targeting of mitochondrial respiratory complex I and activation of AMP-kinase
Hannah R. Bridges et al.
BMC BIOLOGY (2016)
Myc Expression Drives Aberrant Lipid Metabolism in Lung Cancer
Zoe Hall et al.
CANCER RESEARCH (2016)
Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton
Hai Hu et al.
CELL (2016)
Metabolic Heterogeneity in Human Lung Tumors
Christopher T. Hensley et al.
CELL (2016)
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
Shawn M. Davidson et al.
CELL METABOLISM (2016)
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand et al.
Cell Metabolism (2016)
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor et al.
CLINICAL CANCER RESEARCH (2016)
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
Robert U. Svensson et al.
NATURE MEDICINE (2016)
A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer
Y. Ma et al.
ONCOGENE (2016)
Molecular Imaging of Prostate Cancer
Andreas G. Wibmer et al.
RADIOGRAPHICS (2016)
Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
Jared R. Mayers et al.
SCIENCE (2016)
AMP-activated protein kinase mediates mitochondrial fission in response to energy stress
Erin Quan Toyama et al.
SCIENCE (2016)
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
Issam Ben-Sahra et al.
SCIENCE (2016)
MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4
Candice Sun Hong et al.
CELL REPORTS (2016)
Metabolic imaging in Prostate Cancer: where we Are
Claudia Testa et al.
FRONTIERS IN ONCOLOGY (2016)
Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma
Jae Pil Hwang et al.
PLOS ONE (2016)
The preoperative SUVmax for 18F-FDG uptake predicts survival in patients with colorectal cancer
Debing Shi et al.
BMC CANCER (2015)
Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers
Milica Momcilovic et al.
CANCER RESEARCH (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation
Alex J. Bott et al.
CELL METABOLISM (2015)
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer
Viviana De Rosa et al.
CLINICAL CANCER RESEARCH (2015)
Molecular imaging of hypoxia in non-small-cell lung cancer
Connie Yip et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer
Mohamed Hassanein et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation
Katherine Sellers et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Imaging Metabolism with Hyperpolarized 13C-Labeled Cell Substrates
Kevin M. Brindle
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
NRF2 regulates serine biosynthesis in non-small cell lung cancer
Gina M. DeNicola et al.
NATURE GENETICS (2015)
Functional expression of sodium-glucose transporters in cancer
Claudio Scafoglio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Shuyu Wang et al.
SCIENCE (2015)
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Sriram Venneti et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
MYC and metabolism on the path to cancer
Annie L. Hsieh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
L-Arginine Depletion Blunts Antitumor T-cell Responses by Inducing Myeloid-Derived Suppressor Cells
Matthew Fletcher et al.
CANCER RESEARCH (2015)
A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma
Paul A. Stewart et al.
PLOS ONE (2015)
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Hannah R. Bridges et al.
BIOCHEMICAL JOURNAL (2014)
Epidermal Growth Factor Receptor ( EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
Hideki Makinoshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
[18F](2S,4S)-4-(3-Fluoropropyl)glutamine as a Tumor Imaging Agent
Zehui Wu et al.
MOLECULAR PHARMACEUTICS (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α
Brandon Faubert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
John D. Hayes et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Transformation by Amplified FGFR1 in Lung Cancer
Florian Malchers et al.
CANCER DISCOVERY (2014)
MYC Regulation of Cell Growth through Control of Transcription by RNA Polymerases I and III
Kirsteen J. Campbell et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Regional distribution of SGLT activity in rat brain in vivo
Amy S. Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
David B. Shackelford et al.
CANCER CELL (2013)
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Luika A. Timmerman et al.
CANCER CELL (2013)
Metabolic Regulation by p53 Family Members
Celia R. Berkers et al.
CELL METABOLISM (2013)
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Mohamed Hassanein et al.
CLINICAL CANCER RESEARCH (2013)
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Laura Soucek et al.
GENES & DEVELOPMENT (2013)
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
Anju Singh et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1
Issam Ben-Sahra et al.
SCIENCE (2013)
Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
Aaron M. Robitaille et al.
SCIENCE (2013)
A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1
Liron Bar-Peled et al.
SCIENCE (2013)
Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer
Yan Liu et al.
CANCER DISCOVERY (2013)
MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB
Jose A. Martina et al.
AUTOPHAGY (2012)
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Yoichiro Mitsuishi et al.
CANCER CELL (2012)
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels tomTORC1
Liron Bar-Peled et al.
CELL (2012)
Early [F-18]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung
Ryo Takahashi et al.
CLINICAL CANCER RESEARCH (2012)
Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for Imaging xC Transporter Using Positron Emission Tomography in Patients with Non-Small Cell Lung or Breast Cancer
Sora Baek et al.
CLINICAL CANCER RESEARCH (2012)
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Carmine Settembre et al.
EMBO JOURNAL (2012)
PET/CT imaging in different types of lung cancer: An overview
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Metformin in cancer: translational challenges
Ryan J. O. Dowling et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-18F-Fluoro-β-D-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-18F-Fluoro-β-L-Arabinofuranosyl)-5-Methylcytosine PET
Jason T. Lee et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents
Karl Ploessl et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
Zhao Chen et al.
NATURE (2012)
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
Barbara Chaneton et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation
Matthew D. Wilkerson et al.
PLOS ONE (2012)
The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis
Agnes Roczniak-Ferguson et al.
SCIENCE SIGNALING (2012)
Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine Treatment
Daniel Braas et al.
CANCER DISCOVERY (2012)
Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
Kate D. Sutherland et al.
CANCER CELL (2011)
LKB1 Mutations Frequently Detected in Mucinous Bronchioloalveolar Carcinoma
Atsushi Osoegawa et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Matthias R. Benz et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine
Brian P. Lieberman et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Maria M. Mihaylova et al.
NATURE CELL BIOLOGY (2011)
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Joungmok Kim et al.
NATURE CELL BIOLOGY (2011)
Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Daniel F. Egan et al.
SCIENCE (2011)
Beneficial Role of Nrf2 in Regulating NADPH Generation and Consumption
Kai Connie Wu et al.
TOXICOLOGICAL SCIENCES (2011)
Diagnostic value of 18F-FDG PET/CT and dedicated bone imaging in childhood sarcoma
Franziska Walter et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Functional expression of SGLTs in rat brain
Amy S. Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents
Anke de Vries et al.
BIOMATERIALS (2010)
Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids
Yasemin Sancak et al.
CELL (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells
Daisuke Nakada et al.
NATURE (2010)
The Lkb1 metabolic sensor maintains haematopoietic stem cell survival
Sushma Gurumurthy et al.
NATURE (2010)
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells
Boyi Gan et al.
NATURE (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Detection and Quantification of the Evolution Dynamics of Apoptosis Using the PET Voltage Sensor 18F-Fluorobenzyl Triphenyl Phosphonium
Igal Madar et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
Tumor Vascular Permeability to a Nanoprobe Correlates to Tumor-Specific Expression Levels of Angiogenic Markers
Efstathios Karathanasis et al.
PLOS ONE (2009)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography
Rachel E. Laing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET
Hung-Jen Hsieh et al.
ANNALS OF NUCLEAR MEDICINE (2008)
ATP Citrate Lyase: Activation and Therapeutic Implications in Non-Small Cell Lung Cancer
Toshiro Migita et al.
CANCER RESEARCH (2008)
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer
Amy L. Vavere et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analog
Caius G. Radu et al.
NATURE MEDICINE (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1
Yasemin Sancak et al.
SCIENCE (2008)
Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro
James A. Dykens et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
L-3-11C-lactate as a PET tracer of myocardial lactate metabolism:: A feasibility study
Pilar Herrero et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Lung cancer in never smokers - a different disease
Sophie Sun et al.
NATURE REVIEWS CANCER (2007)
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji et al.
NATURE (2007)
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors
Helen Su et al.
CLINICAL CANCER RESEARCH (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Xuewu Zhang et al.
CELL (2006)
Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors
Katerina Politi et al.
GENES & DEVELOPMENT (2006)
A liposomal nanoscale contrast agent for preclinical CT in mice
S Mukundan et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
Direct comparison of F-18-FDG and C-11-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
K Van Laere et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
RJ Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways
R Sordella et al.
SCIENCE (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Evaluation of MYC E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays
JW Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Long-residence-time nano-scale liposomal lohexol for X-ray-based blood pool imaging
CY Kao et al.
ACADEMIC RADIOLOGY (2003)
Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression
H Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation
N Bardeesy et al.
NATURE (2002)
FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?
CS Yap et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Characterization of acetate metabolism in tumor cells in relation to cell proliferation: Acetate metabolism in tumor cells
M Yoshimoto et al.
NUCLEAR MEDICINE AND BIOLOGY (2001)
Pemetrexed: A multitargeted antifolate agent with promising activity in solid tumors
AA Adjei
ANNALS OF ONCOLOGY (2000)
Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine:: [18F]FLT for imaging of cellular proliferation in vivo
JR Grierson et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Share Paper
